SCHEMBL8089108

SCHEMBL8089108

CCCCC=CC(=O)NO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB11 A5LHX3 1/20 0.45
PSMA7 O14818 1/20 0.45
PSMB1 P20618 1/20 0.45
PSMA1 P25786 1/20 0.45
PSMA2 P25787 1/20 0.45
PSMA3 P25788 1/20 0.45
PSMA4 P25789 1/20 0.45
PSMB8 P28062 1/20 0.45
PSMB9 P28065 1/20 0.45
PSMA5 P28066 1/20 0.45
PSMB4 P28070 1/20 0.45
PSMB6 P28072 1/20 0.45
PSMB5 P28074 1/20 0.45
PSMB10 P40306 1/20 0.45
PSMB3 P49720 1/20 0.45
PSMB2 P49721 1/20 0.45
PSMA6 P60900 1/20 0.45
PSMA8 Q8TAA3 1/20 0.45
PSMB7 Q99436 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5791472 0.94 PSMB11 (0.51) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL5791476 0.94 PSMB11 (0.51) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL5794871 0.92 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL5794870 0.92 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL8089119 0.92 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL31306995 0.92 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL8089117 0.86
SCHEMBL30163450 0.84 CNR1 (0.49) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL29498993 0.83 PSMB11 (0.45) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL270119 0.81 HDAC6 (0.39) TAS1R3TAS1R1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758361-B1 POLYMERISABLE COMPOSITION AND THE USE THEREOF NOVARTIS AG (CH) 2000-11-15 EP disclosed
US-5852126-A Polymerisable composition and the use thereof NOVARTIS AG (CH) 1998-12-22 US disclosed